Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 842 shares (grant or award)
  2. 4 Grant or award Director acquired 1,497 shares (grant or award)
  3. 4 Open-market sale Chief Discovery Officer sold 31,515 shares at $13.88 ($437,428)
  4. 4 Grant or award Director acquired 404 shares (grant or award)
  5. 4 Grant or award Director acquired 809 shares (grant or award)
  6. 4 Grant or award Director acquired 1,438 shares (grant or award)
  7. 4 Grant or award Director acquired 404 shares (grant or award)
  8. 4 Grant or award Director acquired 12,866 shares (grant or award)
  9. 4 Grant or award Director acquired 12,866 shares (grant or award)
  10. 4 Grant or award Director acquired 12,866 shares (grant or award)
  11. 4 Grant or award Director acquired 12,866 shares (grant or award)
  12. 4 Grant or award Director acquired 12,866 shares (grant or award)
  13. 4 Grant or award Director acquired 12,866 shares (grant or award)
  14. 4 Grant or award Director acquired 12,866 shares (grant or award)
  15. 4 Grant or award Director acquired 12,866 shares (grant or award)
  16. 4 Grant or award Director acquired 12,866 shares (grant or award)
  17. 4 Grant or award Director acquired 12,866 shares (grant or award)
  18. 4 Grant or award Director acquired 12,866 shares (grant or award)
  19. 4 Grant or award Director acquired 569 shares (grant or award)
  20. 4 Grant or award Director acquired 1,138 shares (grant or award)

Page 9 of 49 · 965 filings